Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Senju Pharma claims new polypeptides for corneal epithelial disorders

April 19, 2011

ChemoCentryx presents new CMKLR1 receptor ligands

April 18, 2011

N30 Pharma presents new inhibitors of alcohol dehydrogenase class-3

April 18, 2011

Novel lysophospholipid S1P1 receptor agonists described by Almirall

April 18, 2011

Czech researchers present new platinum complexes with antitumor activity

April 18, 2011

New activators of nuclear receptor related 1 receptor claimed

April 18, 2011

Enanta prepares new HCV NS5A inhibitors

April 15, 2011

New 17-beta-HSD 3 inhibitors prepared by Sumitomo

April 14, 2011

Recordati discloses novel metabotropic glutamate mGlu5 receptor antagonists

April 14, 2011

Suven patents novel serotonin 5-HT4 receptor modulators

April 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...